Pirinixic Acid Aminothiazole - CAS:1492060-44-2

您当前的位置：

Pirinixic Acid Aminothiazole (Synonyms:5-LO/mPGES1-IN-1)

目录号 : KCM11550 CAS No. : 1492060-44-2 纯度 : ≥98%

Data Sheet 产品使用指南

Microsomal prostaglandin E synthase-1 (mPGES-1) and 5-lipoxygenase (5-LO) are key enzymes in the synthesis of PGE and leukotrienes (LTs), respectively. PGE and LTs are bioactive lipids that contribute to a broad range of pathologies, including inflammation and various forms of cancer. Pirinixic acid aminothiazole is a dual inhibitor of mPGES-1 and 5-LO (ICs = 0.4 and 0.2 µM, respectively). It is a weak inhibitor of COX-1 and -2 and has no effect on 12- and 15-LO isoforms. Pirinixic acid aminothiazole reduces the synthesis of PGE and LTC during zymosan-induced peritonitis in mice, resulting in a significantly diminished inflammatory response.

规格	价格	是否有货	数量
1mg		In-stock
5mg		In-stock
10mg		In-stock
25mg		In-stock

加入购物车大包装询价

Other Forms of Rapamycin:

Pirinixic Acid Aminothiazole In-stock
CAY10678 In-stock
PF-9184 In-stock
Zomepirac-d4 sodium salt In-stock
HQL-79 In-stock

KKL Med 的所有产品和服务仅用于科学研究，不能被用于人体，兽医，我们也不向个人提供产品和服务。

生物活性

Pirinixic Acid Aminothiazole is a dual inhibitor of microsomal prostaglandin E2 synthase-1 (mPGES-1) and 5-lipoxygenase (5-LO). IC50 values are 0.3 and 0.4 μM, respectively. Pirinixic Acid Aminothiazole has anti-inflammatory activity.

体内研究

Pirinixic Acid Aminothiazole (10 mg/kg, intraperitoneal injection, pre-treatment 30 minutes before peritonitis induction) can reduce vascular permeability and inflammatory cell infiltration in a zymosan induced mouse peritonitis model, accompanied by impaired levels of cysteine leukotrienes and prostaglandin E2.

Animal Model:	Zymosan-Induced Peritonitis in Mice
Dosage:	10 mg/kg
Administration:	i.p. pretreated 30 minutes before peritonitis induction
Result:	Reduced vascular permeability by 57% and inhibited neutrophil infiltration by 45%.

分子式

C₂₅H₂₅ClN₄O₂S₂

分子量

513.1

CAS号

1492060-44-2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Powder	-20°C	3 years
In solvent	-80°C	6 months
	-20°C	1 month

纯度： ≥98%

Data Sheet

产品使用指南

暂无相关参考文献

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量

浓度

体积

分子量*

重置计算

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2

浓度

体积

浓度

体积

重置计算

动物实验计算换算器

第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量）

给药剂量

mg/kg

动物平均体重

每只动物给药体积

动物数量

只

第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系客服为您提供正确的澄清溶液配方）

% DMSO

% Tween 80

% ddH₂O

% DMSO

计算重置

计算结果:

工作液浓度： mg/ml；

DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，注：如该浓度超过该批次药物DMSO溶解度，请先联系客服）；

体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL ddH₂O，混匀澄清。

配置后的溶液总体积：

注意：1. 首先保证母液是澄清的；
2. 一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。

Other Forms of Rapamycin:

KKL 顾客使用本产品发表的 0 篇科研文献

The molarity calculator equation

The dilution calculator equation

动物实验计算换算器